Home » Providence

Providence

Ladipoe – Providence

Mavin Records presents this brand new song titled “Providence” from Ladipoe out now.  Nigerian music star Ladipoe unleashes this amazing Afrofusion tune “Providence“. The new track is taken off his new extended play “Providence“. Before this new project, Ladipoe dropped hit records like “Running” and “Feeling“. The “Providence” EP has 6 tracks and features from Rema, Fireboy and Amaarae who add spice to the project. We are sure this tune would be a hit amongst fans and even further. Listen, enjoy Ladipoe – “Providence” below & share. Download link coming soon… You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process...

2023: Kogi commissioner tackles Ohanaeze over zoning

Mr Kingsley Fanwo, Kogi State Commissioner for Information and Communications, has reacted to comments by Igbo socio-political group, Ohanaeze Ndigbo on Gov. Yahaya Bello’s assertion about rotation of Nigerian presidency among the different regions of the country. Bello had during a maiden edition of the ‘Governor Yahaya Bello seminar for political and crime correspondents’ in Abuja on Friday, described rotational Presidency as “unconstitutional.” The Governor, who has also declared his intention to run for the presidency in 2023 added that “Nigerians should be allowed to make their choices for the best candidate to emerge for the top post”. But reacting to the claim, Ohanaeze Ndigbo which has been at the vanguard of the clamour that a Nigerian of South-East origin should succeed President...

US election: Republicans hold back Democrats, narrowing path to Senate control

The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...

Gold rises on renewed US stimulus hope, dollar falls

Spot gold rose 0.3 percent to $1,910.56 an ounce at 3:37pm, New York time, after falling as much as 0.5 percent. Gold rose on renewed optimism for a preelection aid package in the U.S., while the dollar fell to a one-week low. House Speaker Nancy Pelosi said a bill for a compromise stimulus package is being written as she awaits a key phone call with Treasury Secretary Steven Mnuchin. Senate Majority Leader Mitch McConnell said his chamber would take up a comprehensive coronavirus package if an accord is struck. The Bloomberg Dollar Spot Index headed for the third straight decline. Pelosi said in a Bloomberg Television interview that while there are areas where more work is required to get a compromise, she was pleased with the Trump administration’s latest position on coronavirus testing ...

Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine

Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...